Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 263-267

  Peters, Verena ^a   Jansen, Erwin E W ^b   Jakobs, Cornelis ^b   Riedl, Eva ^c   Janssen, Bart ^d   Yard, Benito A ^c   Wedel, Johannes ^c   Hoffmann, Georg F ^a   Zschocke, Johannes ^e   Gotthardt, Daniel ^d   Fischer, Christine ^d   Köppel, Hannes ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anserine; Carnosinase; Carnosinase deficiency; Carnosine; CN1; Histidine dipeptides; Homocarnosine; Liver cirrhosis

Indexed keywords

ANSERINE; CARNOSINASE 1; CARNOSINE; ENZYME; GLUCOSE; HOMOCARNOSINE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CNDP1 MANNHEIM GENE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

ADULT; ANSERINE; CARNOSINE; DIPEPTIDASES; FEMALE; HISTIDINE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650255648     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.10.016     Document Type: Article

References (30)

1. Janssen B., Hohenadel D., Brinkkoetter P., et al. Carnosine as a protective factor in diabetic nephropathy. Association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005, 54:2320-2327.
2. Freedman B.I., Bostrom M., Daeihagh P., Bowden D.W. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007, 2:1306-1316.
3. Mooyaart A.L., van Valkengoed I.G., Shaw P.K., et al. Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diab Res Clin Pract 2009, 85:272-278.
4. Teufel M., Saudek V., Ledig J.P., et al. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 2003, 278:6521-6531.
5. Lenney J.F., Georg R.P., Weiss A.M., Kucera C.M., Chan P.W., Rinzler G.S. Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta 1982, 123:221-231.
6. Bando K., Shimotsuji T., Toyoshima H. Fluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathy. Ann Clin Biochem 1984, 21:510-514.
7. Peters V., Kebbewar M., Jansen E.W., et al. Relevance of allosteric confirmations and homocarnosine concentration on carnosinase (CN1) activity. Amino Acids 2009, 38:1607-1615.
8. Neidle A., Kandera J. Carnosine-an olfactory bulb peptide. Brain Res 1974, 80:359-364.
9. Boldyrev A.A., Severin S.E. The histidine-containing dipeptides, carnosine and anserine: distribution, properties and biological significance. Adv Enzyme Regul 1990, 30:175-194.
10. Boldyrev A.A. Does carnosine possess direct antioxidant activity?. Int J Biochem 1990, 25:1101-1107.
11. Mozdan M., Szemraj J., Rysz J., Nowak D. Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. Basic Clin Pharmacol Toxicol 2005, 96:352-360.
12. Hou W.C., Chen H.J., Lin Y.H. Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification. J Agric Food Chem 2003, 51:1706-1709.
13. Gjessing L.R., Lunde H.A., Morkrid L., Lenney J.F., Sjaastad O. Inborn errors of carnosine and homocarnosine metabolism. J Neural Transm Suppl 1990, 29:91-106.
14. Duane P., Peters T.J. Serum carnosinase activities in patients with alcoholic chronic skeletal muscle myopathy. Clin Sci (Lond) 1988, 75:185-190.
15. Wassif W.S., Sherwood S.A., Amir A. Serum carnosinase activities in central nervous system disorders. Clin Chim Acta 1994, 225:57-64.
16. Balion C.M., Benson C., Raina P.S., Papaioannou A., Patterson C., Ismaila A.S. Brain type carnosinase in dementia: a pilot study. BMC Neurol 2007, 7:38.
17. Bando K., Ichihara K., Toyoshima H., et al. Decreased activity of carnosinase in serum of patients with chronic liver disorders. Clin Chem 1986, 32:1563-1565.
18. Schönherr J. Analysis of products of animal origin in feeds by determination of carnosine and related dipeptides by high-performance liquid chromatography. J Agric Food Chem 2002, 27:1945-1950.
19. Jansen E.E.W., Gibson K.M., Shigematsu Y., Jakobs C., Verhoeven N.M. A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 830:196-200.
20. Gil-Agusti M., Esteve-Romero J., Carda-Broch S. Anserine and carnosine determination in meat samples by pure micellar liquid chromatography. J Chromatogr A 2008, 1189:444-450.
21. Yeum K.J., Oriolo M., Regazzoni L., et al. Profiling histidine dipeptides in plasma and urine after ingesting beef, chicken or chicken broth in humans. Amino Acids 2010, 38:847-858.
22. Baguet A., Reyngoudt H., Pottier A., et al. Carnosine loading and washout in human skeletal muscles. J Appl Physiol 2009, 106:837-842.
23. Kim H.J. Comparison of the carnosine and taurine contents of bastus lateralis of elderly Korean males, with impaired glucose tolerance, and young elite Korean swimmers. Amino Acids 2009, 36:359-363.
24. Tallon M.J., Harrsi R.C., Maffulli N., Tarnpolsky M.A. Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects. Biogerontology 2007, 8:12-137.
25. Stuerenberg H.J., Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscles. Arch Gerontol Geriatr 1999, 29:107-113.
26. Harris R.C., Tallon M.J., Dunnett M., et al. The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids 2006, 30:279-289.
27. Park E.Y., Murakami H., Matsumura Y. Effects of addition of amino acids and peptides on lipid oxidation in a powdery model system. J Agric Food Chem 2005, 19:8334-8341.
28. Gardner M.L., Illingworth K.M., Kelleher J., Wood D. Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose. J Physiol 1991, 439:411-422.
29. Jappar D., Hu Y., Keep R.F., Smith D.E. Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters. Pharm Res 2009, 26:172-181.
30. McDonough C.W., Hicks P.J., Lu L., Langefeld C.D., Freedman B.I., Bowden D.W. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Hum Genet 2009, 126:265-275.